The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis

OBJECTIVE: Post hoc analysis of pooled data from nine randomised controlled trials to assess the effect of tofacitinib (oral Janus kinase inhibitor for treatment of rheumatoid arthritis (RA) and psoriatic arthritis (PsA)) on residual pain in patients with RA or PsA with abrogated inflammation. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Dougados, Maxime, Taylor, Peter C, Bingham, Clifton O, Fallon, Lara, Brault, Yves, Roychoudhury, Satrajit, Wang, Lisy, Kessouri, Meriem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Pain
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454076/
https://www.ncbi.nlm.nih.gov/pubmed/36814062
http://dx.doi.org/10.1136/rmdopen-2022-002478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454076/
https://www.ncbi.nlm.nih.gov/pubmed/36814062
http://dx.doi.org/10.1136/rmdopen-2022-002478

Ejemplares similares